In This Section

Third JCA-AACR Precision Cancer Medicine International Conference: New Frontiers in Precision Cancer Medicine through Innovative Modalities

June 28-30, 2025
Kyoto Tokyu Hotel
Kyoto, Japan

EXTENDED Abstract Submission Deadline: Wednesday, May 14, 12 p.m. JST (CLOSED)
EXTENDED Registration (On-site) Deadline: Friday, June 27, 2025, 5 p.m. JST
Registration Deadline for Live Online Viewing: Thursday, June 19, 2025, 5 p.m. JST

CONFERENCE COCHAIRS

Motohiro Kato, University of Tokyo, Tokyo, Japan
Victor E. Velculescu, Johns Hopkins University, Baltimore, Maryland, USA

Organizing Committee:

Philippe L. Bedard, University Health Network, Toronto, Ontario, Canada
Francesca deMichelis, University of Trento, Trento, Italy
Peter K. Sorger, Harvard University, Boston, Massachusetts, USA
Marcel R.M. van den Brink, City of Hope, Duarte, California, USA
Toshihiko Doi, National Cancer Center Hospital East, Japan
Takeshi Kohno, National Cancer Center, Tokyo, Japan
Hiroyoshi Nishikawa, Kyoto University, Kyoto, Japan
Emi Nishimura, University of Tokyo, Tokyo, Japan
Mamiko Sakata, Tsukuba University, Tsukuba, Japan

The JCA-AACR Precision Cancer Medicine International Conference is held every two to three years in Japan. This international collaboration will bring together the greatest minds from the United States, Japan, and around the world to share the latest and most exciting developments in precision cancer medicine. Led by conference cochairs Victor E. Velculescu and Motohiro Kato, the program will address timely topics such as advances in genome data science, hematologic malignancies, clonal hematopoiesis, pediatric cancer, immunotherapy, and cancer progression and treatment.